SCIENTIFIC INDUSTRIES INC - SCND STOCK NEWS

Scientific Industries, Inc. (OTCQB:SCND) announced a research collaboration with Valerian Materials, NCERC, and UMN to utilize its DOTS software platform for advancing bioprocessing. This initiative is part of a broader project funded by the Biden Administration, which aims to invest over $2 billion in biotechnology. The DOTS platform is now integrated into six of the top fifteen academic synthetic biology pilot plants in the U.S., offering a faster and more economical alternative to traditional workflows. This collaboration highlights the growing market traction for DOTS.

Scientific Industries (OTCQB:SCND) announced the launch of an upgraded VIVID® automated pill counter aimed at enhancing pharmacy operations. This redesigned device features a Total Inventory Solution that tracks non-dispensable drugs, ensuring safety and compliance. Additionally, its faster counting engine improves efficiency and accuracy, while enhanced pharmacy management system integration streamlines workflows. The new cloud-based VIVID Plus Subscription offers extensive data analytics and support services, promoting operational efficiency in pharmacies as they prepare for the upcoming trade show season.

Scientific Industries (OTCQB: SCND) reported its financial results for Q3 and nine months ending March 31, 2022, revealing a 14.2% increase in net revenues to $2.9 million and 19.0% increase to $8.6 million year-to-date. Bioprocessing Systems Operations saw significant growth, with revenues rising 201.1% to $0.4 million for Q3. Despite these gains, the company reported a net loss of $1.5 million for Q3, with losses increasing from the previous year. A conference call is scheduled for May 18, 2022, at 4:30 p.m. ET.

Scientific Industries, Inc. (OTCQB:SCND) is set to release its financial results for the third quarter of fiscal year 2022 on May 16, 2022, after market closure. A press release detailing these results will be available on May 17, 2022, before the market opens. The company will host an investor conference call on May 18, 2022, at 4:30 p.m. ET to discuss the financial outcomes. Scientific Industries specializes in laboratory equipment and bioprocessing solutions, which are essential for research in various scientific fields.

Scientific Industries, Inc. (OTCQB:SCND) will participate in the Lytham Partners Spring 2022 Investor Conference from April 4-7, 2022. The company’s presentation is scheduled for 11:00 a.m. ET on April 4, available via webcast on its website. Management will also engage in virtual one-on-one meetings during the event.

Scientific Industries specializes in laboratory equipment and bioprocessing tools, with products widely used in research across various institutions. For more details, visit www.scientificindustries.com.

Scientific Industries (OTCQB:SCND) has successfully secured approximately $3 million from new and existing shareholders to enhance its digitally simplified bioprocessing platform. The funding will facilitate accelerated investment in product development and sales for its bioprocessing offerings. Following the acquisition of aquila biolabs in April 2021, the company aims to lead innovations in non-invasive, online monitoring solutions. With around $14 million in cash, the company is positioned for growth in a rapidly expanding market.

Scientific Industries (OTCQB:SCND) reported strong revenue growth for the second quarter and six-month periods ending December 31, 2021. Net revenues increased by 6.9% to $2.9 million and by 21.6% to $5.8 million, driven by significant bioprocessing sales, which surged 91.9% and 143.4% in respective periods. Despite a gross profit margin of 48.5% and 50.7%, the company faced losses of $896,500 ($0.14/share) and $2,105,300 ($0.33/share) for the same periods due to increased operating expenses. Cash and investments stood at $11.2 million, with working capital at $14.8 million.

Scientific Industries, Inc. (OTCQB:SCND) has partnered with BioMADE to enhance educational resources in biotechnology across 20 U.S. community and technical colleges. This initiative aims to provide students with access to advanced bioprocessing technology, including real-time biomass monitoring and training tools. The collaboration has resulted in a $650,000 funding award to develop affordable bioprocessing curricula. Institutions will receive $16,000 worth of equipment at no cost to enrich hands-on learning experiences, underscoring a commitment to building a skilled workforce in the growing bioindustrial sector.

Scientific Industries (OTCQB:SCND) announced its participation in the Lytham Partners Winter 2021 Investor Conference from December 13-16, 2021. The company plans to host a webcasted Fireside Chat on December 13 at 11:00 A.M. ET, focusing on its vision for 2022, along with 1x1 virtual investor meetings. The webcast can be accessed on the Company's website or via a designated link and will be available for replay post-event. For meeting arrangements, interested parties can contact Lytham Partners.